Post-earnings recap
Reported
Thu, Jul 30, 2015
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
ResMed's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. The stock's slight increase of 0.36% reflects investor confidence in the company's performance. However, the lack of revenue data and guidance leaves some uncertainty about future growth prospects.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.68 | N/A | +5.59% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the EPS results, highlighting ongoing efforts in innovation. They emphasized a commitment to growth despite not providing specific guidance.
We are pleased with our EPS performance this quarter.
Our focus remains on innovation and market expansion.